Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jim Xiang

Showing results (121-130 of 169) with videos related to

Pageof 17
Sort By:
Biochemical and Biophysical Research Communications|February 4, 2017
CD40 agonist converting CTL exhaustion via the activation of the mTORC1 pathway enhances PD-1 antagonist action in rescuing exhausted CTLs in chronic infectionAizhang Xu, Rong Wang, Andrew Freywald, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 2010
Dendritic cells recruit T cell exosomes via exosomal LFA-1 leading to inhibition of CD8+ CTL responses through downregulation of peptide/MHC class I and Fas ligand-mediated cytotoxicityYufeng Xie, Haifeng Zhang, Wei Li, et al.
Journal of Opioid Management|December 20, 2013
Immediate-release tapentadol or oxycodone for treatment of acute postoperative pain after elective arthroscopic shoulder surgery: a randomized, phase IIIb studyGary J Vorsanger, Angela M Klopfer, Jim Xiang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 8, 2008
Antigen specificity acquisition of adoptive CD4+ regulatory T cells via acquired peptide-MHC class I complexesSiguo Hao, Jinying Yuan, Shulin Xu, et al.
Journal of Cellular Biochemistry|February 19, 2016
Simulated Microgravity Promotes Cell Apoptosis Through Suppressing Uev1A/TICAM/TRAF/NF-κB-Regulated Anti-Apoptosis and p53/PCNA- and ATM/ATR-Chk1/2-Controlled DNA-Damage Response PathwaysTuo Zhao, Xin Tang, Channakeshava Sokke Umeshappa, et al.
American Journal of Therapeutics|March 11, 2010
Tramadol hydrochloride extended-release once-daily in the treatment of osteoarthritis of the knee and/or hip: a double-blind, randomized, dose-ranging trialByron P DeLemos, Jim Xiang, Carmela Benson, et al.
Vaccine|February 9, 2018
Heterologous human/rat HER2-specific exosome-targeted T cell vaccine stimulates potent humoral and CTL responses leading to enhanced circumvention of HER2 tolerance in double transgenic HLA-A2/HER2 miceYufeng Xie, Jie Wu, Aizhang Xu, et al.
Current Medical Research and Opinion|January 30, 2007
Randomized study of tramadol/acetaminophen versus placebo in painful diabetic peripheral neuropathyRoy Freeman, Philip Raskin, David J Hewitt, et al.
International Journal of Molecular Sciences|April 3, 2014
Transgene IL-6 enhances DC-stimulated CTL responses by counteracting CD4+25+Foxp3+ regulatory T cell suppression via IL-6-induced Foxp3 downregulationKalpana Kalyanasundaram Bhanumathy, Bei Zhang, Khawaja Ashfaque Ahmed, et al.
Vaccine|March 17, 2011
GP120-specific exosome-targeted T cell-based vaccine capable of stimulating DC- and CD4(+) T-independent CTL responsesRoopa Hebbandi Nanjundappa, Rong Wang, Yufeng Xie, et al.
Pageof 17

Showing results (121-130 of 169) with videos related to

Sort By:
Pageof 17
Biochemical and Biophysical Research Communications|February 4, 2017
CD40 agonist converting CTL exhaustion via the activation of the mTORC1 pathway enhances PD-1 antagonist action in rescuing exhausted CTLs in chronic infectionAizhang Xu, Rong Wang, Andrew Freywald, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 2010
Dendritic cells recruit T cell exosomes via exosomal LFA-1 leading to inhibition of CD8+ CTL responses through downregulation of peptide/MHC class I and Fas ligand-mediated cytotoxicityYufeng Xie, Haifeng Zhang, Wei Li, et al.
Journal of Opioid Management|December 20, 2013
Immediate-release tapentadol or oxycodone for treatment of acute postoperative pain after elective arthroscopic shoulder surgery: a randomized, phase IIIb studyGary J Vorsanger, Angela M Klopfer, Jim Xiang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 8, 2008
Antigen specificity acquisition of adoptive CD4+ regulatory T cells via acquired peptide-MHC class I complexesSiguo Hao, Jinying Yuan, Shulin Xu, et al.
Journal of Cellular Biochemistry|February 19, 2016
Simulated Microgravity Promotes Cell Apoptosis Through Suppressing Uev1A/TICAM/TRAF/NF-κB-Regulated Anti-Apoptosis and p53/PCNA- and ATM/ATR-Chk1/2-Controlled DNA-Damage Response PathwaysTuo Zhao, Xin Tang, Channakeshava Sokke Umeshappa, et al.
American Journal of Therapeutics|March 11, 2010
Tramadol hydrochloride extended-release once-daily in the treatment of osteoarthritis of the knee and/or hip: a double-blind, randomized, dose-ranging trialByron P DeLemos, Jim Xiang, Carmela Benson, et al.
Vaccine|February 9, 2018
Heterologous human/rat HER2-specific exosome-targeted T cell vaccine stimulates potent humoral and CTL responses leading to enhanced circumvention of HER2 tolerance in double transgenic HLA-A2/HER2 miceYufeng Xie, Jie Wu, Aizhang Xu, et al.
Current Medical Research and Opinion|January 30, 2007
Randomized study of tramadol/acetaminophen versus placebo in painful diabetic peripheral neuropathyRoy Freeman, Philip Raskin, David J Hewitt, et al.
International Journal of Molecular Sciences|April 3, 2014
Transgene IL-6 enhances DC-stimulated CTL responses by counteracting CD4+25+Foxp3+ regulatory T cell suppression via IL-6-induced Foxp3 downregulationKalpana Kalyanasundaram Bhanumathy, Bei Zhang, Khawaja Ashfaque Ahmed, et al.
Vaccine|March 17, 2011
GP120-specific exosome-targeted T cell-based vaccine capable of stimulating DC- and CD4(+) T-independent CTL responsesRoopa Hebbandi Nanjundappa, Rong Wang, Yufeng Xie, et al.
Pageof 17